PreTAGGED urgent papers 2022 August

Aus coViki
Version vom 18. August 2022, 18:37 Uhr von Ossip Groth (Diskussion | Beiträge)
(Unterschied) ← Nächstältere Version | Aktuelle Version (Unterschied) | Nächstjüngere Version → (Unterschied)
Wechseln zu: Navigation, Suche
homepage
hottest actual papers

coviki.org was constructed in may 2020 at less than 10.000 published papers by pubmed accessibility. it was possible to keep up with human-bassed assortment of papers into subject topics. 2021 is at 62k papers at june 9th and 2020...

I will show here the most remarkable appearing papers as I got noticed at initally screening the pubmed readouts.

preTAGGED urgent papers 2022 October
preTAGGED urgent papers 2022 September
preTAGGED urgent papers 2022 August
preTAGGED urgent papers 2022 July
preTAGGED urgent papers 2022 June
preTAGGED urgent papers 2022 May
preTAGGED urgent papers 2022 April
preTAGGED urgent papers 2022 March
preTAGGED urgent papers 2022 February
preTAGGED urgent papers 2022 January

preTAGGED urgent papers 2021 December
preTAGGED urgent papers 2021 November
preTAGGED urgent papers 2021 October
PreTAGGED urgent papers 2021 September
PreTAGGED urgent papers 2021 August
PreTAGGED urgent papers 2021 July
PreTAGGED urgent papers
2021 Jan-Jun
Unproven ideas
2020 intersting papers
Temporary citations
anything to be included but not shifted into topics yet

0801


35702735 2022. Building a reverse dictionary with specific application to the COVID-19 pandemic.

35643308 2022. SARS-CoV-2 transmission from infected owner to household dogs and cats is associated with food sharing.


35654561 2022. REMOVED: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database.
35682757 2022. The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection.
35743031 2022. Human Superantibodies to 3CL(pro) Inhibit Replication of SARS-CoV-2 across Variants.
35711011 2022. Emergency myelopoiesis in critical illness: lessons from the COVID-19 pandemic.
35634577 2022. Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection.
35756895 2022. Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19.
35675509 2022. Antibody-Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers.
35695891 2022. A close shave: How SARS-CoV-2 induces the loss of cilia.
35674692 2022. SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity.
35676568 2022. Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia.
35683485 2022. The Role of Heparin in COVID-19: An Update after Two Years of Pandemics.

35743491 2022. Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients.


35708626 2022. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.

35768681 2022. Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans.
35712857 2022. Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies.


35700866 2022. Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.
35639922 2022. A distinct dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients.

35658098 2022. Deep Denoising of Raw Biomedical Knowledge Graph From COVID-19 Literature, LitCovid, and Pubtator: Framework Development and Validation.


35662463 2022. PEPPI: Whole-proteome Protein-protein Interaction Prediction through Structure and Sequence Similarity, Functional Association, and Machine Learning.
35747583 2022. Myopia: Mechanisms and Strategies to Slow Down Its Progression.
35720802 2022. Enigma of the high prevalence of anti-SARS-CoV-2 antibodies in HIV-positive people with no symptoms of COVID-19 in Burkina Faso.

35653049 2022. Metformin therapy in COVID-19: inhibition of NETosis.


35663631 2022. Proteomic Analyses Unveil Actionable Disease Pathways in COVID-19: A Step Toward Targeted Therapies.
35763298 2022. Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.
35730564 2022. Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections.
35709336 2022. Combating COVID-19 Using Generative Adversarial Networks and Artificial Intelligence for Medical Images: Scoping Review.
35702397 2022. Immunologic Responses Following COVID-19 Vaccination in Patients with Membranous Nephropathy Receiving Anti-CD38 Felzartamab Therapy: Results from the Phase 1b/2a M-PLACE Study.
35637695 2022. Osmotic Tubulopathy and Acute Thrombotic Microangiopathy in a Kidney Transplant Recipient With a Breakthrough SARS-CoV-2 Infection.
35713613 2022. Culturing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Diagnosis and Genome Sequencing.

35643099 2022. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.
35752184 2022. 2 years of the Access to COVID-19 Tools-Accelerator.


35636438 2022. Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients.
35714658 2022. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.

35743886 2022. COVID-19 on Chest CT: Translating Known Microscopic Findings to Imaging Observations.


35757386 2022. A Theory of Frustration and Its Effect.
35730280 2022. A complex network model for a society with socioeconomic classes.

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis